Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Current Assets:
Cash and Cash Equivalents	$ 1,124,730	$ 162,152
Accounts Receivable	173,443	232,602
Notes Receivable (inclusive of $738,138 and $452,775 in advances to Helomics)	1,801,479	497,276
Inventories	289,023	241,066
Prepaid Expense and other assets	265,584	318,431
Total Current Assets	3,654,259	1,451,527
Notes Receivable		1,112,524
Fixed Assets, net	148,709	180,453
Intangibles, net	950,049	964,495
Lease Right-of-Use Assets	333,944
Total Assets	5,086,961	3,708,999
LIABILITIES AND STOCKHOLDERS' EQUITY
Accounts Payable	432,198	445,689
Note Payable – Bridge Loan Net of Discount of $646,524 and $969,786	1,812,037	1,327,942
Notes Payable – Net of Discount of $352,961 and $63,028	1,267,039	306,972
Accrued Expenses	797,599	1,279,114
Derivative Liability	353,210	272,745
Deferred Revenue	20,929	23,065
Current Lease Liability	78,819
Total Current Liabilities	4,761,831	3,655,527
Lease Liability	255,125
Total Liabilities	5,016,956	3,655,527
Stockholders’ Equity:
Common Stock, $.01 par value, 100,000,000 authorized, 17,360,144 and 14,091,748 outstanding	173,601	140,917
Additional paid-in capital	66,296,741	63,019,708
Accumulated Deficit	(66,401,129)	(63,107,945)
Total Stockholders' Equity	70,005	53,472
Total Liabilities and Stockholders' Equity	5,086,961	3,708,999
Series B Convertible Preferred Stock [Member]
Stockholders’ Equity:
Series B Convertible Preferred Stock, $.01 par value, 20,000,000 authorized, 79,246 and 79,246 outstanding	$ 792	$ 792